AMENDMENT(S) PROPOSED BY THE HOUSE

HEALTH, WELFARE AND INSTITUTIONS

1. Line 30, introduced, after patient

strike

the remainder of line 30, all of line 31, and through required on line 32

HEALTH, WELFARE AND INSTITUTIONS

2. Line 45, introduced, after He

insert

or, if he is incapable of making an informed decision, his legally authorized representative

HEALTH, WELFARE AND INSTITUTIONS

3. At the beginning of line 98, introduced

insert

A.

HEALTH, WELFARE AND INSTITUTIONS

4. After line 102, introduced

insert

B. Notwithstanding any other provision of law to the contrary, a manufacturer of an investigational drug, biological product, or device that makes an investigational drug, biological product, or device available to a person who meets the criteria set forth in subsection A of § 54.1-3442.2 shall be immune from civil liability for any adverse action, condition, or other outcome resulting from the patient’s use of the investigational drug, biological product, or device, absent gross negligence or willful misconduct.